SANUWAVE Health, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
SANUWAVE Health, Inc. (SNWV) reported Revenue from Contract with Customer, Excluding Assessed Tax of $11.42 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-11-06
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $11.42M, a 22.94% increase year-over-year.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $10.15M, a 43.36% increase year-over-year.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $9.29M, a 63.46% increase year-over-year.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $10.28M, a 57.44% increase year-over-year.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $32.33M, a 67.91% increase from fiscal 2023.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $19.25M, a 24.14% increase from fiscal 2022.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $15.51M, a 36.26% increase from fiscal 2021.
- SANUWAVE Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $11.38M, a 213.75% increase from fiscal 2020.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $11.42M 10-Q · filed 2025-11-06 | $21.57M derived: sum of 2 quarters · filed 2025-11-06 | $30.86M 10-Q · filed 2025-11-06 | $41.14M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2025-06-30 | $10.15M 10-Q · filed 2025-08-07 | $19.44M 10-Q · filed 2025-08-07 | $29.72M derived: sum of 3 quarters · filed 2025-08-07 | $39.01M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2025-03-31 | $9.29M 10-Q · filed 2025-05-08 | $19.57M derived: sum of 2 quarters · filed 2025-05-08 | $28.86M derived: sum of 3 quarters · filed 2025-11-06 | $35.94M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-12-31 | $10.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $19.57M derived: sum of 2 quarters · filed 2025-11-06 | $26.65M derived: sum of 3 quarters · filed 2025-11-06 | $32.33M 10-K · filed 2025-03-20 | ||||
| 2024-09-30 | $9.29M 10-Q · filed 2025-11-06 | $16.37M derived: sum of 2 quarters · filed 2025-11-06 | $22.05M 10-Q · filed 2025-11-06 | $28.58M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $7.08M 10-Q · filed 2025-08-07 | $12.76M 10-Q · filed 2025-08-07 | $19.29M derived: sum of 3 quarters · filed 2025-08-07 | $24.11M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $5.68M 10-Q · filed 2025-05-08 | $12.21M derived: sum of 2 quarters · filed 2025-05-08 | $17.03M derived: sum of 3 quarters · filed 2025-05-08 | $21.45M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $11.35M derived: sum of 2 quarters · filed 2025-03-20 | $15.76M derived: sum of 3 quarters · filed 2025-03-20 | $19.25M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $4.82M 10-Q · filed 2024-11-07 | $9.23M derived: sum of 2 quarters · filed 2024-11-07 | $12.73M 10-Q · filed 2024-11-07 | $17.93M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $4.41M 10-Q · filed 2024-08-12 | $7.91M 10-Q · filed 2024-08-12 | $13.11M derived: sum of 3 quarters · filed 2024-08-12 | $17.03M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $3.49M 10-Q · filed 2024-05-09 | $8.70M derived: sum of 2 quarters · filed 2024-05-09 | $12.62M derived: sum of 3 quarters · filed 2024-05-09 | $16.15M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $9.12M derived: sum of 2 quarters · filed 2024-03-21 | $12.66M derived: sum of 3 quarters · filed 2024-03-21 | $15.51M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $3.92M 10-Q · filed 2023-11-09 | $7.46M derived: sum of 2 quarters · filed 2023-11-09 | $10.31M 10-Q · filed 2023-11-09 | $12.94M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $3.54M 10-Q · filed 2023-08-10 | $6.39M 10-Q · filed 2023-08-10 | $9.02M derived: sum of 3 quarters · filed 2023-08-10 | $12.75M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $2.85M 10-Q · filed 2023-05-11 | $5.49M derived: sum of 2 quarters · filed 2023-05-11 | $9.21M derived: sum of 3 quarters · filed 2023-05-11 | $11.84M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $6.36M derived: sum of 2 quarters · filed 2023-03-31 | $8.99M derived: sum of 3 quarters · filed 2023-03-31 | $11.38M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $3.73M 10-Q · filed 2022-02-28 | $6.36M derived: sum of 2 quarters · filed 2022-08-12 | $8.75M 10-Q · filed 2022-02-28 | $10.25M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-06-30 | $2.63M 10-Q · filed 2022-08-12 | $2.91M 10-Q · filed 2022-01-14 | $4.50M 10-Q · filed 2022-08-12 | $5.03M 10-Q · filed 2022-01-14 | $6.53M derived: sum of 3 quarters · filed 2022-08-12 | $7.89M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $1.86M 10-Q · filed 2022-05-26 | $2.12M 10-Q · filed 2021-12-13 | $3.89M derived: sum of 2 quarters · filed 2022-05-26 | $5.26M derived: sum of 3 quarters · filed 2022-05-26 | $5.34M derived: sum of 4 quarters · filed 2022-05-26 | |||
| 2020-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-13 | $3.40M derived: sum of 2 quarters · filed 2022-05-13 | $3.48M derived: sum of 3 quarters · filed 2022-05-13 | $3.63M 10-K · filed 2022-05-13 | $4.06M 10-K · filed 2021-10-21 | |||
| 2020-09-30 | $1.37M 10-Q · filed 2022-02-28 | $1.97M 10-Q · filed 2020-11-23 | $1.45M derived: sum of 2 quarters · filed 2022-02-28 | $1.60M 10-Q · filed 2022-02-28 | $2.20M 10-Q · filed 2020-11-23 | $1.93M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $83.00K 10-Q · filed 2022-01-14 | $232.00K 10-Q · filed 2022-01-14 | $568.15K derived: sum of 3 quarters · filed 2022-01-14 | $765.79K derived: sum of 4 quarters · filed 2022-01-14 | ||||
| 2020-03-31 | $149.00K 10-Q · filed 2021-12-13 | $485.15K derived: sum of 2 quarters · filed 2021-12-13 | $682.79K derived: sum of 3 quarters · filed 2021-12-13 | |||||
| 2019-12-31 | $336.15K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-10-21 | $533.79K derived: sum of 2 quarters · filed 2021-10-21 | $1.03M 10-K · filed 2021-10-21 | |||||
| 2019-09-30 | $197.64K 10-Q/A · filed 2021-07-01 | $692.58K 10-Q/A · filed 2021-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |